Co-Founder, Chairman, CEO

Chief Commercial Officer (CCO)

Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review

Certain Common Stock of Celcuity Inc. are subject to a Lock-Up Agreement Ending on 29-SEP-2025.

Certain Pre-Funded Warrants of Celcuity Inc. are subject to a Lock-Up Agreement Ending on 29-SEP-2025.

Celcuity Inc.(NasdaqCM:CELC) added to S&P Biotechnology Select Industry Index

Vice President, Drug Safety & Pharmacovigilance

Celcuity is a clinical-stage biotechnology company focused on developing targeted therapies for cancer treatment. They are seeking a Vice President of Drug Safety & Pharmacovigilance to lead the strategic vision for the department, ensuring compliance with safety regulations and overseeing risk-benefit assessments throughout the product lifecycle.

Vice President, Commercial Operations

Vice Preseident Medical Affairs

Executive Director Medical Resources

Sign up with Google

Sign in with Google